EDGAR GARZA: Open Payments
NPI 1184980674 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 11 payments from 8 companies in 2025. Trend: 2023 $569 · 2024 $91 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $125 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Corcept Therapeutics | 2 | $45 |
| Lilly USA, LLC | 1 | $29 |
| PFIZER INC. | 1 | $28 |
| Novo Nordisk Inc | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: DUPIXENT, SHINGRIX, Korlym, ZEPBOUND, PREVNAR 20, Wegovy, Dexcom G6 Transmitter, M-M-R II.
Industry payments across CA — which companies pay providers there.
